Peers of Ernexa Therapeutics Inc (ERNA)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
6137.50x
As of Dec 30, 2025
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Dec 30, 2025 | 6137.50x |
| Dec 29, 2025 | 6137.50x |
| Dec 26, 2025 | 6451.50x |
| Dec 24, 2025 | 6922.50x |
| Dec 23, 2025 | 6687.00x |
| Dec 22, 2025 | 7001.00x |
| Dec 19, 2025 | 7236.50x |
| Dec 18, 2025 | 6844.00x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison